VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_16-vv-00616 Package ID: USCOURTS-cofc-1_16-vv-00616 Petitioner: David A. Johnson Filed: 2017-04-04 Decided: 2017-12-06 Vaccine: influenza Vaccination date: 2015-09-28 Condition: Guillain-Barré Syndrome (GBS) Outcome: compensated Award amount USD: 200000 AI-assisted case summary: David A. Johnson filed a petition for compensation under the National Vaccine Injury Compensation Program on May 25, 2016. He alleged that an influenza vaccine he received on September 28, 2015, caused him to suffer Guillain-Barré Syndrome (GBS) and its residual effects for more than six months. The respondent denied that the influenza vaccine caused his GBS or any other injury. However, on April 4, 2017, the parties filed a joint stipulation for compensation. Chief Special Master Nora Beth Dorsey found the stipulation reasonable and adopted it as the decision of the Court. David A. Johnson was awarded a lump sum of $200,000.00 as compensation for all items of damages available under the Vaccine Act. The public decision does not describe the specific onset of symptoms, diagnostic tests, treatments, or expert witnesses. Ezra A. Johnson represented the petitioner, and Sarah Christina Duncan represented the respondent. Theory of causation field: Petitioner David A. Johnson alleged that an influenza vaccine administered on September 28, 2015, caused Guillain-Barré Syndrome (GBS) and residual effects lasting over six months. Respondent denied causation. The parties filed a joint stipulation for compensation, which was adopted by Chief Special Master Nora Beth Dorsey. The stipulation resulted in a $200,000.00 lump sum award for all damages. The public decision does not detail the specific theory of causation, medical experts, or the mechanism of injury. The case was handled by petitioner's counsel Ezra A. Johnson and respondent's counsel Sarah Christina Duncan. The decision date was December 6, 2017. Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_16-vv-00616-0 Date issued/filed: 2017-12-06 Pages: 7 Docket text: PUBLIC DECISION (Originally filed: 04/04/2017) regarding 32 DECISION Stipulation/Proffer ( Signed by Chief Special Master Nora Beth Dorsey.)(mpj) Copy to parties. -------------------------------------------------------------------------------- Case 1:16-vv-00616-UNJ Document 40 Filed 12/06/17 Page 1 of 7 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 16-0616V Filed: April 4, 2017 UNPUBLISHED * * * * * * * * * * * * * * * * * * * * * * * * * * * * DAVID A. JOHNSON, * * Petitioner, * Joint Stipulation on Damages; v. * Influenza (“Flu”) Vaccine; Guillain- * Barré Syndrome (“GBS”); Special SECRETARY OF HEALTH * Processing Unit (“SPU”) AND HUMAN SERVICES, * * Respondent. * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * Ezra A. Johnson, Uhl Fitzsimmons Jewett & Burton, PLLC, San Antonio, TX, for petitioner. Sarah Christina Duncan, U.S. Department of Justice, Washington, DC, for respondent. DECISION ON JOINT STIPULATION1 Dorsey, Chief Special Master: On May 25, 2016, David A. Johnson (“petitioner”) filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,2 (the “Vaccine Act”). Petitioner alleges that an influenza (“flu”) vaccine he received on September 28, 2015, caused him to suffer injuries, including Guillain-Barré Syndrome (“GBS”). Petition at 1; Stipulation, filed April 4, 2017, at ¶ 4. Petitioner further alleges that he experienced the residual effects of his injury for more than six months. Petition at 3; Stipulation at ¶ 4. “Respondent denies that the influenza immunization is the cause of petitioner’s alleged GBS or any other injury or his current condition.” Stipulation at ¶ 6. Nevertheless, on April 4, 2017, the parties filed the attached joint stipulation, stating that a decision should be entered awarding compensation. The undersigned 1 Because this unpublished decision contains a reasoned explanation for the action in this case, the undersigned intends to post it on the United States Court of Federal Claims' website, in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). In accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits within this definition, the undersigned will redact such material from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). Case 1:16-vv-00616-UNJ Document 40 Filed 12/06/17 Page 2 of 7 finds the stipulation reasonable and adopts it as the decision of the Court in awarding damages, on the terms set forth therein. Pursuant to the terms stated in the attached Stipulation, the undersigned awards the following compensation: A lump sum of $200,000.00, in the form of a check payable to petitioner. Stipulation at ¶ 8. This amount represents compensation for all items of damages that would be available under 42 U.S.C. § 300aa-15(a). Id. The undersigned approves the requested amount for petitioner’s compensation. In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the court is directed to enter judgment in accordance with this decision.3 IT IS SO ORDERED. s/Nora Beth Dorsey Nora Beth Dorsey Chief Special Master 3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice renouncing the right to seek review. 2 Case 1:16-vv-00616-UNJ Document 40 Filed 12/06/17 Page 3 of 7 Case 1:16-vv-00616-UNJ Document 40 Filed 12/06/17 Page 4 of 7 Case 1:16-vv-00616-UNJ Document 40 Filed 12/06/17 Page 5 of 7 Case 1:16-vv-00616-UNJ Document 40 Filed 12/06/17 Page 6 of 7 Case 1:16-vv-00616-UNJ Document 40 Filed 12/06/17 Page 7 of 7